Radiation From CT Scans Linked to Thyroid Cancer, Leukemia
Elevated risk stronger in women than men; risk for non-Hodgkin lymphoma increased in patients ≤45.
Diagnosis & Disease Information
Factors Associated With Thyroid Cancer Overtreatment Identified
Overtreatment more likely in younger, male, Hispanic or Asian patients, those with extensive lymph node surgery.
Pediatric Thyroid Cancer Rates Are Rising
The increased prevalence may be real, or it could be the result of the detection of more harmless tumors through increased screening efforts.
Does Every Classical Type of Well-differentiated Thyroid Cancer Have Excellent Prognosis? A Case Series and Literature Review
[Cancer Management and Research] A review of 14 cases in which patients with well-differentiated thyroid cancer experienced adverse outcomes after surgical treatment of their disease.
Performance of Work-Related Functions Linked to Cancer Treatment in Adolescent, Young Adult Survivors
Survey results reveal the effects of cancer treatment on job-related mental and physical abilities in survivors who were AYAs at diagnosis.
Mindfulness-based Stress Reduction in Patients With Differentiated Thyroid Cancer Receiving Radioactive Iodine Therapy: A Randomized Controlled Trial
[Cancer Management and Research] This research examines the efficacy of mindfulness-based stress reduction (MBSR) on health-related quality of life, depression, and anxiety in patients with differentiated thyroid cancer receiving radioactive iodine therapy.
Postoperative Radiotherapy Favorable as Adjuvant Treatment for Thymic Neuroendocrine Tumors
A propensity-score matched analysis was used to determine the effect of surgery and postoperative radiotherapy in patients with TNETs.
Lack of Choice Perceived Among Those Treated With RAI for Differentiated Thyroid Cancer
Results of a population-based survey, presented at the 2018 ASCO Quality Care Symposium, revealed patients’ perceptions regarding choice of treatment of differentiated thyroid cancer (DTC).
Dabrafenib-Trametinib Combination Approved for Mutation-Positive Thyroid Cancer
FDA grants approval to immunotherapy combination in the treatment of unresectable and metastatic BRAF V600E mutation-positive anaplastic thyroid cancer (ATC).
Overtreatment a Concern With RAI for Well-Differentiated Thyroid Cancer
In a study from the Cleveland Clinic, researchers investigated the association between well-differentiated thyroid cancer and risk for AML or CML in those patients treated with radioactive iodine.
- Loading...
Loading...
Next post in Head and Neck Cancer
Loading... 
Loading...